The Asia Pacific human leukocyte antigen (HLA) testing market is expected to grow from US$ 154.35 million in 2022 to US$ 243.18 million by 2028; it is estimated to grow at a CAGR of 7.9% from 2022 to 2028.
Living organ donations and deceased organ donations (DCD) are the two types of organ donations. The demand for both types of organ donations is rising day by day due to the elevating cases of chronic illnesses. Additionally, as per the Ministry of Health and Family Welfare (MoHFW) of the Government of India, annually, 500,000 people die because of the non-availability of organs; 200,000 people die due to liver disorders; and 50,000 people die because of heart disease. Moreover, 150,000 people await a kidney transplant, but only 5,000 get kidneys for transplantation. These numbers indicate the need for organ donors, which is much greater than the actual number of donations. Similar scenarios have been found in other nations of the world. To balance the demand and supply of organs, governments of several countries have implemented various strategies to promote organ donation. Such initiatives by governments are creating opportunities for HLA testing market players, as the rise in organ donations and transplantation procedures is likely to propel the demand for HLA testing.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific human leukocyte antigen (HLA) testing market at a notable CAGR during the forecast period.
The Asia Pacific human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country. Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the Asia Pacific human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others. Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others. Based on country, the Asia Pacific human leukocyte antigen (HLA) testing market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific.
THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina, Inc.; Bio-Rad Laboratories, Inc.; TBG Diagnostics Limited; F. HOFFMANN-LA ROCHE LTD.; Takara Bio Inc.; and Luminex Corporation are among the major companies operating in the Asia Pacific human leukocyte antigen (HLA) testing market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 154.35 Million |
| Market Size by 2028 | US$ 243.18 Million |
| CAGR (2022 - 2028) | 7.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product and service
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Human Leukocyte Antigen (HLA) Testing Market is valued at US$ 154.35 Million in 2022, it is projected to reach US$ 243.18 Million by 2028.
As per our report Asia Pacific Human Leukocyte Antigen (HLA) Testing Market, the market size is valued at US$ 154.35 Million in 2022, projecting it to reach US$ 243.18 Million by 2028. This translates to a CAGR of approximately 7.9% during the forecast period.
The Asia Pacific Human Leukocyte Antigen (HLA) Testing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Human Leukocyte Antigen (HLA) Testing Market report:
The Asia Pacific Human Leukocyte Antigen (HLA) Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Human Leukocyte Antigen (HLA) Testing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Human Leukocyte Antigen (HLA) Testing Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Human Leukocyte Antigen (HLA) Testing Market
